Literature DB >> 3102254

Monoclonal BALB/c anti-progesterone antibodies use family IX variable region heavy chain genes.

E Deverson, C Berek, M Taussig, A Feinstein.   

Abstract

Variable region nucleotide sequences and respective translated amino acid sequences for three heavy chains (DB3, 11/32 and 10/8) and two light chains (DB3 and 11/32) of monoclonal mouse IgG1 anti-progesterone antibodies have been determined by primer extension mRNA sequencing. The three VH regions exhibit the same rarely observed VH IX gene family and have greater than 88% homology between them. Two associated light chain sequences are 95% homologous and belong to the V kappa I group. The N-terminal twenty two amino acids of the kappa light chain of the third antibody 10/8 have been determined by automated protein sequencing and are identical to those of 11/32. Thus, these three monoclonal anti-progesterones derived from separate fusions all use VHIX-V kappa 1 gene combinations.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3102254     DOI: 10.1002/eji.1830170103

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

1.  In vitro selection and affinity maturation of antibodies from a naive combinatorial immunoglobulin library.

Authors:  H Gram; L A Marconi; C F Barbas; T A Collet; R A Lerner; A S Kang
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

2.  Blocking of pregnancy in mice by immunization with anti-idiotype directed against monoclonal anti-progesterone antibody.

Authors:  M W Wang; R B Heap; M J Taussig
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

3.  Sequence, specificity and crystallization of an oestrone-3-glucuronide antibody (3910).

Authors:  M He; M Gani; O Livnah; E A Stura; D Beale; J Coley; I A Wilson; M J Taussig
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

4.  Eleven distinct VH gene families and additional patterns of sequence variation suggest a high degree of immunoglobulin gene complexity in a lower vertebrate, Xenopus laevis.

Authors:  R N Haire; C T Amemiya; D Suzuki; G W Litman
Journal:  J Exp Med       Date:  1990-05-01       Impact factor: 14.307

5.  Anti-anti-idiotypic (Ab3) antibodies that bind progesterone-11alpha-bovine serum albumin differ in their combining sites from antibodies raised directly against the antigen.

Authors:  R D Kirsch; D Beale; M He; A L Corper; U Krawinkel-Brenig; M J Taussig
Journal:  Immunology       Date:  2000-06       Impact factor: 7.397

6.  Induction of anti-progesterone immunity and pregnancy blocking by anti-progesterone anti-idiotypes. Variable efficacy of polyclonal Ab2 antibodies directed against a panel of closely related Ab1 antibodies.

Authors:  M W Wang; M J Sims; P R Symington; A S Humphreys; M J Taussig
Journal:  Immunology       Date:  1991-07       Impact factor: 7.397

7.  Blot-sequencing of antibodies: application to analysis of V gene usage among anti-steroid monoclonal antibodies.

Authors:  M J Taussig; P R Symington; M Woods; M J Sims; D Beale; A S Humphreys; A J Northrop; P J Barker; N S Huskisson; J Coley
Journal:  Immunology       Date:  1991-04       Impact factor: 7.397

8.  Characterization of a progesterone-binding, three-domain antibody fragment (VH/K) expressed in Escherichia coli.

Authors:  M He; A S Kang; M Hamon; A S Humphreys; M Gani; M J Taussig
Journal:  Immunology       Date:  1995-04       Impact factor: 7.397

9.  Analysis of an anti-progesterone antibody: variable crystal morphology of the Fab' and steroid-Fab' complexes.

Authors:  E A Stura; J H Arevalo; A Feinstein; R B Heap; M J Taussig; I A Wilson
Journal:  Immunology       Date:  1987-12       Impact factor: 7.397

10.  Heavy chain-only antibodies are spontaneously produced in light chain-deficient mice.

Authors:  Xiangang Zou; Michael J Osborn; Daniel J Bolland; Jennifer A Smith; Daniel Corcos; Maureen Hamon; David Oxley; Amanda Hutchings; Geoff Morgan; Fatima Santos; Peter J Kilshaw; Michael J Taussig; Anne E Corcoran; Marianne Brüggemann
Journal:  J Exp Med       Date:  2007-12-17       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.